Eric Van Cutsem et. al, Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer.

CONDIVIDI SU

Authors
Products
Request information

    Please insert your email address below, we will contact you soon.

    I confirm that I have read the information on the personal data management.

    I agree to the processing of my personal data
    according to the above mentioned information

    *Both options must be selected



    2018-05-14T15:40:11+02:00